Top

Journal of Gastroenterology

Published in:

01-02-2006

The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer

Authors: Yasuo Koga, Yoshihiko Kitajima, Atsushi Miyoshi, Ken Sato, Seiji Sato, Kohji Miyazaki

Published in: Journal of Gastroenterology | Issue 2/2006

Title: The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer
Authors: Yasuo Koga
Yoshihiko Kitajima
Atsushi Miyoshi
Ken Sato
Seiji Sato
Kohji Miyazaki
Publication date: 01-02-2006
Publisher: Springer-Verlag
Published in: Journal of Gastroenterology / Issue 2/2006
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI: https://doi.org/10.1007/s00535-005-1732-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2006

Solid serous adenoma of the pancreas: a solid variant of serous cystadenoma or a separate disease entity?

Management of hepatocellular carcinoma in Japan

Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells

Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B

Update of research and management of hepatitis B

Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials